Gastrointestinal Cancer News

States with expanded Medicaid under the Affordable Care Act demonstrated an increase in cancer diagnoses, especially early-stage cancer diagnoses, according to study results.

Nonalcoholic fatty liver disease correlated significantly with the development of hepatocellular carcinoma and colorectal cancer in men and breast cancer in women, especially among those with a high NAFLD fibrosis score and fibrosis-4 score, according to a recently published study.

The risk for hepatocellular carcinoma recurrence after living donor liver transplantation increased in correlation with higher preoperative platelet count, according to a recently published study.

Investigators found no evidence that regular use of aspirin or NSAIDs increases the risk for pancreatic cancer in a recent study.

A survey of young-onset colorectal cancer survivors showed that many faced barriers to screening due to their age, and that most were initially misdiagnosed and then diagnosed with late-stage disease.

Patients with HIV demonstrated a significantly elevated incidence of anal cancer, with a particularly high risk among patients with AIDS, men who have sex with men and older patients, according to findings published in Journal of Clinical Oncology.

ATLANTA — Survivors of adolescent and young adult hematologic cancers demonstrated increased risk for subsequent malignant neoplasms compared with controls, according to study results presented at ASH Annual Meeting and Exposition.

One in five patients diagnosed with colorectal cancer younger than age 50 showed an inherited genetic predisposition to the disease, yet more than half of these patients lacked a clinical or family history that would typically indicate the need for genetic testing, according to new research.

Patients with colorectal cancer who drank coffee, either caffeinated or decaffeinated, showed a lower risk for colorectal cancer-specific death and overall death in two large prospective cohort studies.

The National Cancer Institute’s Pancreatic Cancer Detection Consortium has awarded a $5.13 million grant to researchers from Baylor Scott & White Research Institute and the Translational Genomics Research Institute, which are developing a blood test for early detection of pancreatic cancer.